Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 108 results.
User Information
Export Records
  1. 1.   NMR 1H, 13C, and 15N resonance assignments of the oncogenic Q61R variant of human NRAS in the active, GTP-bound conformation
  2. Sharma,Alok; Tonelli, Marco; Dyba,Marcin; Esposito,Dominic; Esposito,Dominic; Nissley,Dwight; McCormick, Frank; Maciag,Anna
  3. Biomolecular NMR Assignments. 2025, May 02;
  1. 2.   Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial
  2. Davar, Diwakar; Morrison, Robert M; Dzutsev, Amiran K; Karunamurthy, Arivarasan; Chauvin, Joe-Marc; Amatore, Florent; Deutsch, Julie S; Das Neves, Rodrigo X; Rodrigues,Richard; McCulloch, John A; Wang, Hong; Hartman, Douglas J; Badger, Jonathan H; Fernandes, Miriam R; Bai, Yulong; Sun, Jie; Cole, Alicia M; Aggarwal, Poonam; Fang, Jennifer R; Deitrick, Christopher; Bao, Riyue; Duvvuri, Umamaheswar; Sridharan, Shaum S; Kim, Seungwon W; A Choudry, Haroon; Holtzman, Matthew P; Pingpank, James F; O'Toole, James Patrick; DeBlasio, Richelle; Jin, Yang; Ding, Quanquan; Gao, Wentao; Groetsch, Christopher; Pagliano, Ornella; Rose, Amy; Urban, Corey; Singh, Jagjit; Divarkar, Prajan; Mauro, David; Bobilev, Dmitri; Wooldridge, James; Krieg, Arthur M; Fury, Matthew G; Whiteaker, Jeffrey R; Zhao, Lei; Paulovich, Amanda G; Najjar, Yana G; Luke, Jason J; Kirkwood, John M; Taube, Janis M; Park, Hyun Jung; Trinchieri, Giorgio; Zarour, Hassane M
  3. Cancer Cell. 2024, Oct 30;
  1. 3.   Redox phospholipidomics discovers pro-ferroptotic death signals in A375 melanoma cells in vitro and in vivo
  2. Tyurina, Yulia Y; Kapralov, Alexandr A; Tyurin, Vladimir A; Shurin, Galina; Amoscato, Andrew A; Rajasundaram, Dhivyaa; Tian, Hua; Bunimovich, Yuri L; Nefedova, Yulia; Herrick,William; Parchment,Ralph; Doroshow, James H; Bayir, Hulya; Srivastava,Apurva; Kagan, Valerian E
  3. Redox Biology. 2023, Feb 28; 61: 102650.
  1. 4.   Massively parallel reporter assays and variant scoring identified functional variants and target genes for melanoma loci and highlighted cell-type specificity
  2. Long, Erping; Yin, Jinhu; Funderburk, Karen M; Xu, Mai; Feng, James; Kane, Alexander; Zhang, Tongwu; Myers, Timothy; Golden, Alyxandra; Thakur, Rohit; Kong, Hyunkyung; Jessop, Lea; Kim, Eun Young; Jones, Kristine; Chari,Raj; Machiela, Mitchell J; Yu, Kai; Iles, Mark M; Landi, Maria Teresa; Law, Matthew H; Chanock, Stephen J; Brown, Kevin M; Choi, Jiyeon
  3. American Journal of Human Genetics. 2022, Nov 18;
  1. 5.   Integrated Analysis of Co-expression and Exome Sequencing to Prioritize Susceptibility Genes for Familial Cutaneous Melanoma
  2. Yepes, Sally; Tucker, Margaret A; Koka, Hela; Xiao, Yanzi; Zhang, Tongwu; Jones,Kristine; Vogt,Aurelie; Burdett,Laurie; Luo,Wen; Zhu,Bin; Hutchinson,Amy; Yeager, Meredith; Hicks,Belynda; Brown, Kevin M; Freedman, Neal D; Chanock, Stephen J; Goldstein, Alisa M; Yang, Xiaohong R
  3. The Journal of Investigative Dermatology. 2022, Feb 15;
  1. 6.   A UVB-responsive common variant at chromosome band 7p21.1 confers tanning response and melanoma risk via regulation of the aryl hydrocarbon receptor, AHR
  2. Xu, Mai; Mehl, Lindsey; Zhang, Tongwu; Thakur, Rohit; Sowards, Hayley; Myers, Timothy; Jessop, Lea; Chesi, Alessandra; Johnson, Matthew E; Wells, Andrew D; Michael, Helen T; Bunda, Patricia; Jones, Kristine; Higson, Herbert; Hennessey, Rebecca C; Jermusyk, Ashley; Kovacs, Michael A; Landi, Maria Teresa; Iles, Mark M; Goldstein, Alisa M; Choi, Jiyeon; Chanock, Stephen J; Grant, Struan F A; Chari,Raj; Merlino, Glenn; Law, Matthew H; Brown, Kevin M
  3. American journal of human genetics. 2021, Sep 2; 108(9): 1611-1630.
  1. 7.   Novel MAPK/AKT-impairing germline NRAS variant identified in a melanoma-prone family
  2. Brown, Kevin M; Xu, Mai; Sargen, Michael; Jang,Hyunbum; Zhang,Mingzhen; Zhang, Tongwu; Zhu, Bin; Jones, Kristie; Kim, Jung; Mendoza, Laura; Hayward, Nicholas K; Tucker, Margaret A; Goldstein, Alisa M; Yang, Xiaohong Rose; Stewart, Douglas R; Hicks, Belynda; Consonni, Dario; Pesatori, Angela C; Fargnoli, Maria Concetta; Peris, Ketty; Stratigos, Alex; Menin, Chiara; Ghiorzo, Paola; Puig, Susana; Nagore, Eduardo; Andresson,Thorkell; Nussinov,Ruth; Calista, Donato; Landi, Maria Teresa
  3. Familial cancer. 2021, Jul 03;
  1. 8.   Small-Molecule Natural Product Physachenolide C Potentiates Immunotherapy Efficacy by Targeting BET Proteins
  2. Tewary,Poonam; Brooks, Alan D.; Xu, Ya-Ming; Wijeratne, E. M. Kithsiri; Babyak, Ashley L.; Back, Timothy C.; Chari,Raj; Evans,Christine; Henrich,Curtis; Meyer,Thomas; Edmondson,Elijah; de Aquino, Maria T. Prudente; Kanagasabai, Thanigaivelan; Shanker, Anil; Gunatilaka, A. A. Leslie; Sayers, Thomas J.
  3. Cancer Research. 2021, Jun 15; 81(12): 3374-3386.
  1. 9.   Co-Isolation of Cytokines and Exosomes: Implications for Immunomodulation Studies
  2. Benjamin-Davalos, Shawna; Koroleva, Marina; Allen, Cheryl L.; Ernstoff, Marc S.; La Shu, Shin
  3. Frontiers In Immunology. 2021, Apr 19; 12
  1. 10.   Dabrafenib and Trametinib in Patients With Tumors With BRAFV600E Mutations: Results of the NCI-MATCH Trial Subprotocol H
  2. Salama, April K S; Li, Shuli; Macrae, Erin R; Park, Jong-In; Mitchell, Edith P; Zwiebel, James A; Chen, Helen X; Gray, Robert J; McShane, Lisa M; Rubinstein, Larry V; Patton, David; Williams,Mickey; Hamilton, Stanley R; Armstrong, Deborah K; Conley, Barbara A; Arteaga, Carlos L; Harris, Lyndsay N; O'Dwyer, Peter J; Chen, Alice P; Flaherty, Keith T
  3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2020, NOV 20; 38(33): JCO2000762.
  1. 11.   Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma
  2. Mirabello, Lisa; Zhu, Bin; Koster, Roelof; Karlins,Eric; Dean, Michael; Yeager,Meredith; Gianferante, Matthew; Spector, Logan G; Morton, Lindsay M; Karyadi, Danielle; Robison, Leslie L; Armstrong, Gregory T; Bhatia, Smita; Song, Lei; Pankratz, Nathan; Pinheiro, Maisa; Gastier-Foster, Julie M; Gorlick, Richard; de Toledo, Silvia Regina Caminada; Petrilli, Antonio S; Patino-Garcia, Ana; Lecanda, Fernando; Gutierrez-Jimeno, Miriam; Serra, Massimo; Hattinger, Claudia; Picci, Piero; Scotlandi, Katia; Flanagan, Adrienne M; Tirabosco, Roberto; Amary, Maria Fernanda; Kurucu, Nilgün; Ilhan, Inci Ergurhan; Ballinger, Mandy L; Thomas, David M; Barkauskas, Donald A; Mejia-Baltodano, Gerardo; Valverde, Patricia; Hicks,Belynda; Zhu,Bin; Wang,Mingyi; Hutchinson,Amy; Tucker, Margaret; Sampson, Joshua; Landi, Maria T; Freedman, Neal D; Gapstur, Susan; Carter, Brian; Hoover, Robert N; Chanock, Stephen J; Savage, Sharon A
  3. JAMA oncology. 2020, Mar 19; 6(5): 724-734.
  1. 12.   Targeting the Oncogenic Long Non-coding RNA SLNCR1 by Blocking Its Sequence-Specific Binding to the Androgen Receptor
  2. Schmidt, Karyn; Weidmann, Chase A; Hilimire, Thomas A; Yee, Elaine; Hatfield, Breanne M; Schneekloth,Jay; Weeks, Kevin M; Novina, Carl D
  3. Cell reports. 2020, Jan 14; 30(2): 541-554.e5.
  1. 13.   Report on the 2018 Cancer, Autoimmunity, and Immunology Conference
  2. Curran, Colleen S.; Sommers, Connie L.; Young,Howard; Bourcier, Katarzyna; Mancini, Marie; Sharon, Elad
  3. Journal of immunology (Baltimore, Md. : 1950). 2019, May 15; 202(10): 2823-2828.
  1. 14.   A component overlapping attribute clustering (COAC) algorithm for single-cell RNA sequencing data analysis and potential pathobiological implications
  2. Peng, He; Zeng, Xiangxiang; Zhou, Yadi; Zhang, Defu; Nussinov,Ruth; Cheng, Feixiong
  3. PLoS computational biology. 2019, Feb 19; 15(2):
  1. 15.   Sex-specific gene and pathway modeling of inherited glioma risk
  2. Ostrom, Quinn T.; Coleman, Warren; Huang, William; Rubin, Joshua B.; Lathia, Justin D.; Berens, Michael E.; Speyer, Gil; Liao, Peter; Wrensch, Margaret R.; Eckel-Passow, Jeanette E.; Armstrong, Georgina; Rice, Terri; Wiencke, John K.; McCoy, Lucie S.; Hansen, Helen M.; Amos, Christopher I.; Bernstein, Jonine L.; Claus, Elizabeth B.; Houlston, Richard S.; Il'yasova, Dora; Jenkins, Robert B.; Johansen, Christoffer; Lachance, Daniel H.; Lai, Rose K.; Merrell, Ryan T.; Olson, Sara H.; Sadetzki, Siegal; Schildkraut, Joellen M.; Shete, Sanjay; Andersson, Ulrika; Rajaraman, Preetha; Chanock,Stephen; Linet, Martha S.; Wang, Zhaoming; Yeager, Meredith; Melin, Beatrice; Bondy, Melissa L.; Barnholtz-Sloan, Jill S.; Freeman, Laura E. Beane; Koutros, Stella; Albanes, Demetrius; Visvanathan, Kala; Stevens, Victoria L.; Henriksson, Roger; Michaud, Dominique S.; Feychting, Maria; Ahlbom, Anders; Giles, Graham G.; Giles, Graham G.; Milne, Roger; McKean-Cowdin, Roberta; Le Marchand, Loic; Stampfer, Meir; Ruder, Avima M.; Carreon, Tania; Hallmans, Goran; Zeleniuch-Jacquotte, Anne; Gaziano, J. Michael; Sesso, Howard D.; Purdue, Mark P.; White, Emily; Peters, Ulrike; Buring, Julie
  3. NEURO-ONCOLOGY. 2019, JAN; 21(1): 71-82.
  1. 16.   Combination therapy of tumor-targeting Salmonella typhimurium A1-R and oral recombinant methioninase regresses a BRAF-V600E-negative melanoma
  2. Kawaguchi, Kei; Higuchi, Takashi; Li, Shukuan; Han, Qinghong; Tan, Yuying; Igarashi, Kentaro; Zhao, Ming; Miyake, Kentaro; Kiyuna, Tasuku; Miyake, Masuyo; Ohshiro, Hiromichi; Sugisawa, Norihiko; Zhang, Zhiying; Razmjooei, Sahar; Wangsiricharoen, Sintawat; Chmielowski, Bartosz; Nelson, Scott D; Russell, Tara A; Dry, Sarah M; Li, Yunfeng; Eckardt, Mark A; Singh, Arun S; Singh, Shree Ram; Eilber, Fritz C; Unno, Michiaki; Hoffman, Robert M
  3. Biochemical and Biophysical Research Communications. 2018, Sep 18; 503(4): 3086-3092.
  1. 17.   Phase I Trial of M7824 (MSB0011359C), a Bifunctional Fusion Protein Targeting PD-L1 and TGF beta, in Advanced Solid Tumors
  2. Strauss, Julius; Heery, Christopher R.; Schlom, Jeffrey; Madan, Ravi A.; Cao, Liang; Kang, Zhigang; Lamping, Elizabeth; Marte, Jennifer L.; Donahue, Renee N.; Grenga, Italia; Cordes, Lisa; Christensen, Olaf; Mahnke, Lisa; Helwig, Christoph; Gulley, James L.
  3. Clinical Cancer Research. 2018, Mar 15; 24(6): 1287-1295.
  1. 18.   Rare germline variants in known melanoma susceptibility genes in familial melanoma
  2. Goldstein, Alisa M.; Xiao, Yanzi; Sampson, Joshua; Zhu, Bin; Rotunno, Melissa; Bennett, Hunter; Wen, Yixuan; Jones, Kristine; Vogt, Aurelie; Burdette, Laurie; Luo, Wen; Zhu, Bin; Yeager, Meredith; Hicks, Belynda; Han, Jiali; De Vivo, Immaculata; Koutros, Stella; Andreotti, Gabriella; Beane-Freeman, Laura; Purdue, Mark; Freedman, Neal D.; Chanock, Stephen J.; Tucker, Margaret A.; Yang, Xiaohong R.
  3. Human Molecular Genetics. 2017, Dec 15; 26(24): 4886-4895.
  1. 19.   KIT Suppresses BRAF(V600E)-Mutant Melanoma by Attenuating Oncogenic RAS/MAPK Signaling
  2. Neiswender, James V.; Kortum, Robert L.; Bourque, Caitlin; Kasheta, Melissa; Zon, Leonard I.; Morrison, Deborah; Ceol, Craig J.
  3. Cancer Research. 2017, Nov 01; 77(21): 5820-5830.
  1. 20.   Decoding NADPH oxidase 4 expression in human tumors
  2. Meitzler, Jennifer L; Makhlouf, Hala R; Antony, Smitha; Wu, Yongzhong; Butcher, Donna; Jiang, Guojian; Juhasz, Agnes; Lu, Jiamo; Dahan, Iris; Jansen-Dürr, Pidder; Pircher, Haymo; Shah, Ajay M; Roy, Krishnendu; Doroshow, James H
  3. Redox Biology. 2017, Oct; 13: 182-195.
  1. 21.   IL4 from T Follicular Helper Cells Downregulates Antitumor Immunity
  2. Shirota, Hidekazu; Klinman, Dennis; Ito, Shuku-ei; Ito, Hiroyasu; Kubo, Masato; Ishioka, Chikashi
  3. CANCER IMMUNOLOGY RESEARCH. 2017, Jan; 5(1): 61-71.
  1. 22.   Immunological monitoring of the tumor immunoenvironment for clinical trials
  2. Malyguine, A. M.; Strobl, S. L.; Shurin, M. R.
  3. Cancer Immunology Immunotherapy. 2012, Feb; 61(2): 239-247.
  1. 23.   Trafficking of a Dual-Modality Magnetic Resonance and Fluorescence Imaging Superparamagnetic Iron Oxide-Based Nanoprobe to Lymph Nodes
  2. Bumb, A.; Regino, C. A. S.; Egen, J. G.; Bernardo, M.; Dobson, P. J.; Germain, R. N.; Choyke, P. L.; Brechbiel, M. W.
  3. Molecular Imaging and Biology. 2011, Dec; 13(6): 1163-1172.
  1. 24.   Th17 Cells Are Long Lived and Retain a Stem Cell-like Molecular Signature
  2. Muranski, P.; Borman, Z. A.; Kerkar, S. P.; Klebanoff, C. A.; Ji, Y.; Sanchez-Perez, L.; Sukumar, M.; Reger, R. N.; Yu, Z. Y.; Kern, S. J.; Roychoudhuri, R.; Ferreyra, G. A.; Shen, W.; Durum, S. K.; Feigenbaum, L.; Palmer, D. C.; Antony, P. A.; Chan, C. C.; Laurence, A.; Danner, R. L.; Gattinoni, L.; Restifol, N. P.
  3. Immunity. 2011, Dec; 35(6): 972-985.
  1. 25.   Lack of germline PALB2 mutations in melanoma-prone families with CDKN2A mutations and pancreatic cancer
  2. Yang, X. H. R.; Jessop, L.; Myers, T.; Amundadottir, L.; Pfeiffer, R. M.; Wheeler, W.; Pike, K. M.; Yuenger, J.; Burdett, L.; Yeager, M.; Chanock, S. J.; Tucker, M. A.; Goldstein, A. M.
  3. Familial Cancer. 2011, Sep; 10(3): 545-548.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel